Wu Qing,Dong Baiqiang,Jin Jianan,Hang Qingqing,Liu Xiaohui,Xu Yujin,Chen Ming.Comparison of the efficacy of stereotactic body radiotherapy and surgery for intrapulmonary recurrence patients after non-small cell lung cancer surgery[J].Chinese Journal of Radiological Medicine and Protection,2022,42(11):857-864
Comparison of the efficacy of stereotactic body radiotherapy and surgery for intrapulmonary recurrence patients after non-small cell lung cancer surgery
Received:July 02, 2022  
DOI:10.3760/cma.j.cn112271-20220702-00277
KeyWords:Non-small cell lung cancer  Stereotactic body radiation therapy  Surgical treatment  Intrapulmonary recurrence
FundProject:浙江省医药卫生科技项目(2020KY079);北京希思科领航肿瘤研究项目(Y-2019AZMS-0061);北京科创医学发展基金会项目(KC2021-JX-0186-63)
Author NameAffiliationE-mail
Wu Qing The Second Clinical Medical College of Zhejiang Chinese Medicine University, Hangzhou 310053, China  
Dong Baiqiang Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China  
Jin Jianan Phase I Clinical Trial Ward, Cancer Hospital Affiliated to University of Chinese Academy of Science, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Hang Qingqing The Second Clinical Medical College of Zhejiang Chinese Medicine University, Hangzhou 310053, China  
Liu Xiaohui The Second Clinical Medical College of Zhejiang Chinese Medicine University, Hangzhou 310053, China  
Xu Yujin Department of Chest Radiotherapy, Cancer Hospital Affiliated to University of Chinese Academy of Science, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Chen Ming Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China chenming@sysucc.org.cn 
Hits: 1540
Download times: 448
Abstract::
      Objective To compare the efficacy of stereotactic body radiotherapy(SBRT) and surgery in treating intrapulmonary recurrence of non-small cell lung cancer (NSCLC) after radical surgery.Methods A retrospective analysis was conducted on NSCLC patients, who underwent radical surgery at the Cancer Hospital Affiliated to University of Chinese Academy of Sciences from November 2012 to December 2018 and then received SBRT or secondary surgery because of postoperative intrapulmonary recurrence. The survival rates of these patients were calculated using the Kaplan-Meier method. The comparison between the two groups was made using the Log-rank method, and the univariate and multivariate analysis was made using the Cox regression method.Results Among 62 eligible patients, 33 received SBRT and 29 received secondary surgery, and they were divided into the SBRT group and the surgery group accordingly. For the SBRT and surgery groups, the median follow-up time was 45.8 months and 37.4 months, the 3-year locoregional control rate (LRCR) 79.8% and 90.2%, respectively (P > 0.05), the progression-free-survival (PFS) 58.5% and 42.3%, respectively (P >0.05), and the overall survival (OS) 78.0% and 85.5%, respectively (P >0.05). The multivariate analysis suggested that treatment method, Charlson comorbidity index (CCI), and adjuvant drug therapy were independent prognostic factors for PFS (P = 0.027, 0.013, 0.001).Conclusions The efficacy of SBRT and surgery is comparable for patients with intrapulmonary recurrence of NSCLC after radical surgery.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9059431  On-line:0

v
Scan QR Code
&et=8C10CEA789A144B8D97FFA0DF64E418DFA4217AE1B30CE7D1E7B23432D412C106A6C33FA7B9E11F4CD832BF0189D7F9BCBE226C9DFFBA6CCE040308E732DBCE91DBFDB578EC339D0C80DDAE6D75CD83EEF9EC10F9DCA52323065DE8F64FD7286D9D3EFF969C7B9B14FE811370FE1BC0F8EB96475743B7B8EABF6B3D4B03AC151B4864309F5233BD9331A34CB8C31F97D8A409E56CFA4458F178DD0ABC09418CF&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=885CEFEC57DA488F&aid=A774FB5325A1D53FD7A6C1597F51D465&vid=&iid=708DD6B15D2464E8&sid=E002FF26604EFFAB&eid=F90340A344159B2E&fileno=20221105&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="885CEFEC57DA488F"; var my_aid="A774FB5325A1D53FD7A6C1597F51D465";